Patents by Inventor Christopher J. Flaim

Christopher J. Flaim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Temperature controlling device for aerosol drug delivery
    Patent number: 7143766
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation. Warming the air of an aerosol makes it possible to reduce the diameter of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the diameter of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: December 5, 2006
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Joan Rosell, Avi Eliahu, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Patent number: 6845216
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: January 18, 2005
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Publication number: 20040163646
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation. Warming the air of an aerosol makes it possible to reduce the diameter of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the diameter of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 26, 2004
    Applicant: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Joan Rosell, Avi Eliahu, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Publication number: 20040105665
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Application
    Filed: July 11, 2003
    Publication date: June 3, 2004
    Applicant: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Patent number: 6694975
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation. Warming the air of an aerosol makes it possible to reduce the diameter of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the diameter of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: February 24, 2004
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Joan Rosell, Avi Eliahu, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Patent number: 6629526
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: October 7, 2003
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Publication number: 20020112723
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation. Warming the air of an aerosol makes it possible to reduce the diameter of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the diameter of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Application
    Filed: September 20, 2001
    Publication date: August 22, 2002
    Inventors: Jeffrey A. Schuster, Joan Rosell, Avi Eliahu, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Publication number: 20010032647
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Application
    Filed: April 20, 2001
    Publication date: October 25, 2001
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Patent number: 6263872
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: October 16, 2000
    Date of Patent: July 24, 2001
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim
  • Temperature controlling device for aerosol drug delivery
    Patent number: 6131570
    Abstract: A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the size of the aerosol particles to be in the range required for systemic drug delivery independent of ambient conditions. Smaller particles can be more precisely targeted to different areas of the respiratory tract.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: October 17, 2000
    Assignee: Aradigm Corporation
    Inventors: Jeffrey A. Schuster, Christopher J. Flaim